ARTICLE | Company News
BioBlocks, MannKind deal
November 24, 2008 8:00 AM UTC
The companies extended by one year their January 2007 deal to use BioBlocks' medicinal chemistry technology to perform lead optimization for MannKind against undisclosed targets. The partnership has a...